Testosterone
- Generic Name
- Testosterone
- Brand Names
- Androderm, Androgel, Axiron, Fortesta, Natesto, Striant, Testim, Testopel, Vogelxo
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O2
- CAS Number
- 58-22-0
- Unique Ingredient Identifier
- 3XMK78S47O
- Background
Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.
Testosterone was isolated from samples and also synthesized in 1935.
- Indication
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
- Associated Conditions
- Hypergonadotropic Hypogonadism, Hypogonadotrophic Hypogonadism, Idiopathic Hypogonadotropic Hypogonadism, Puberty, Delayed, Inoperable, metastatic Breast cancer
Vogelxo(R) ABPM Study in Hypogandal Men
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 122
- Registration Number
- NCT04558567
- Locations
- 🇺🇸
Upsher-Smith Clinical Trial Site #1, Miami, Florida, United States
🇺🇸Upsher-Smith Clinical Trials Site #8, San Antonio, Texas, United States
🇺🇸Upsher-Smith Clinical Trial Site #2, Anaheim, California, United States
Testopel ® vs. Generic Testosterone Pellets.
- Conditions
- Hypogonadism
- Interventions
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 75
- Registration Number
- NCT04523480
- Locations
- 🇺🇸
University of Miami, Department of Urology, Miami, Florida, United States
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality
- First Posted Date
- 2020-07-30
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Lars Møller Pedersen
- Target Recruit Count
- 7
- Registration Number
- NCT04492553
- Locations
- 🇩🇰
Herlev University Hospital, Herlev, Denmark
🇩🇰Copenhagen University Hospital, Copenhagen, Denmark
🇩🇰Zealand University Hospital, Roskilde, Denmark
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
- Conditions
- Hypogonadism, MaleHypogonadotropic HypogonadismHypogonadism
- Interventions
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Endo Pharmaceuticals
- Target Recruit Count
- 673
- Registration Number
- NCT04456296
- Locations
- 🇺🇸
Endo Clinical Trial Site #22, Tucson, Arizona, United States
🇺🇸Endo Clinical Trial Site #3, Oviedo, Florida, United States
🇺🇸Endo Clinical Trial Site #27, Glen Burnie, Maryland, United States
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
- Conditions
- Hypogonadism, Male
- Interventions
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 81
- Registration Number
- NCT04439799
- Locations
- 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
Effects of External Testosteron Intake on the Choroid: Enhance-depth Imaging Optical Coherence Tomography Study
- Conditions
- Effects of the External Testosteron Intake Over the Choroids of the Patients With Androgen Deficiency
- Interventions
- First Posted Date
- 2020-04-10
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- Neon Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04342247
- Locations
- 🇹🇷
Volkan YETER, Samsun, Turkey
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
- Conditions
- Dyspareunia (Female Excluding Psychogenic)HypoestrogenismArousal Disorders, SexualHypoactive Sexual Desire DisorderMenopause Related ConditionsVulvovaginal Disease
- Interventions
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- University of Florence
- Target Recruit Count
- 81
- Registration Number
- NCT04336891
- Locations
- 🇮🇹
Andrology, Women's Endocrinology and Gender Incongruence Unit, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
Hormone Secretion in Transgender Males
- Conditions
- HealthyTransgender
- Interventions
- First Posted Date
- 2020-03-25
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- University of California, San Diego
- Target Recruit Count
- 40
- Registration Number
- NCT04321551
A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants
- First Posted Date
- 2020-03-25
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Allergan
- Target Recruit Count
- 168
- Registration Number
- NCT04320745
- Locations
- 🇺🇸
Coastal Clinical Research, LLC, An AMR Co., Mobile, Alabama, United States
🇺🇸Regional Urology, LLC, Shreveport, Louisiana, United States
🇺🇸Associated Urologist of North Carolina, Raleigh, North Carolina, United States
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
- Conditions
- Hypogonadism, MaleCancerFatigue
- Interventions
- Other: placebo gel
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2025-03-11
- Target Recruit Count
- 230
- Registration Number
- NCT04301765
- Locations
- 🇺🇸
Georgia Cancer Center at Augusta University, Augusta, Georgia, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.